Ranol SR: Advanced Angina Management with Sustained Nitrate Therapy
| Product dosage: 40mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.56 | $50.18 (0%) | 🛒 Add to cart |
| 180 | $0.38 | $100.36 $68.25 (32%) | 🛒 Add to cart |
| 270 | $0.32 | $150.54 $86.31 (43%) | 🛒 Add to cart |
| 360 | $0.29
Best per pill | $200.73 $104.38 (48%) | 🛒 Add to cart |
| Product dosage: 80mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.74 | $44.16 (0%) | 🛒 Add to cart |
| 90 | $0.59 | $66.24 $53.19 (20%) | 🛒 Add to cart |
| 120 | $0.51 | $88.32 $61.22 (31%) | 🛒 Add to cart |
| 180 | $0.44 | $132.48 $79.29 (40%) | 🛒 Add to cart |
| 270 | $0.39 | $198.72 $105.38 (47%) | 🛒 Add to cart |
| 360 | $0.37
Best per pill | $264.96 $132.48 (50%) | 🛒 Add to cart |
Similar products
Ranol SR is a specialized extended-release nitrate formulation designed for the prophylactic management of chronic stable angina pectoris. This pharmaceutical innovation provides sustained vasodilation, reducing myocardial oxygen demand and improving exercise tolerance in patients with coronary artery disease. Its sophisticated delivery system ensures stable plasma concentrations over an extended period, offering predictable therapeutic effects with a simplified dosing regimen. Clinicians favor Ranol SR for its balanced pharmacokinetic profile that maintains therapeutic efficacy while minimizing peak-trough fluctuations associated with conventional nitrate formulations.
Features
- Contains isosorbide mononitrate as active pharmaceutical ingredient
- Advanced sustained-release matrix technology
- 12-hour controlled release profile
- Bioavailability of approximately 90%
- Minimal first-pass metabolism
- Stable plasma concentration over dosing interval
- Scored tablets for dose adjustment
- Hydrophilic matrix system for consistent drug release
Benefits
- Provides sustained coronary vasodilation throughout day and night
- Significantly reduces frequency and severity of angina attacks
- Improves exercise capacity and physical performance
- Maintains stable therapeutic effects with twice-daily dosing
- Reduces nitrate tolerance development through optimized delivery
- Enhances quality of life through reliable symptom control
Common use
Ranol SR is primarily indicated for the prophylactic management of chronic stable angina pectoris in patients with documented coronary artery disease. It is prescribed when conventional nitrate therapy proves insufficient or when patients experience variable response to immediate-release formulations. The medication is particularly valuable for patients who require consistent anti-anginal coverage throughout waking hours and during physical exertion. Clinical studies demonstrate its efficacy in reducing both symptomatic and silent ischemic episodes detected during Holter monitoring.
Dosage and direction
The recommended initial dosage is 40 mg twice daily, approximately 12 hours apart. Tablets should be swallowed whole with a glass of water and not crushed or chewed. Administration with food may help minimize potential gastrointestinal discomfort. Dose titration should occur at 3-4 day intervals based on therapeutic response and tolerance, with maximum recommended daily dose of 160 mg. Morning and evening doses should be taken at consistent times to maintain stable plasma concentrations. For elderly patients or those with hepatic impairment, initiation at 20 mg twice daily is recommended.
Precautions
Patients should be advised that abrupt discontinuation may precipitate rebound angina. Regular assessment of blood pressure and heart rate is recommended, particularly during dose escalation. Caution is advised in patients with hypovolemia, hypotension, or hypertrophic cardiomyopathy. Use with care in patients with glaucoma due to potential intraocular pressure effects. Alcohol consumption may enhance vasodilatory effects and should be limited. Patients should be monitored for signs of nitrate tolerance with long-term use.
Contraindications
Ranol SR is contraindicated in patients with known hypersensitivity to nitrates or any component of the formulation. It must not be used concurrently with phosphodiesterase-5 inhibitors (sildenafil, tadalafil, vardenafil) due to risk of severe hypotension. Additional contraindications include acute myocardial infarction with low filling pressure, cardiogenic shock, severe anemia, and increased intracranial pressure. The medication is contraindicated in patients with marked hypotension (systolic pressure <90 mmHg).
Possible side effects
The most frequently reported adverse reactions include headache (approximately 20% of patients), which often diminishes with continued therapy. Dizziness and orthostatic hypotension occur in approximately 5-8% of patients. Less common effects include nausea, flushing, and reflex tachycardia. Rare cases of syncope, dermatitis, and gastrointestinal discomfort have been reported. Approximately 2% of patients discontinue therapy due to side effects, primarily headache. Most adverse reactions are dose-dependent and diminish with dose reduction.
Drug interaction
Concomitant use with other vasodilators, antihypertensive agents, or calcium channel blockers may potentiate hypotensive effects. Concurrent administration with tricyclic antidepressants may increase tachycardia risk. Alcohol, beta-blockers, and diuretics may enhance hypotensive effects. Aspirin may increase nitrate bioavailability. Phosphodiesterase-5 inhibitors cause profound hypotension and are absolutely contraindicated. Monoamine oxidase inhibitors may potentiate vascular effects. Always review complete medication profile before initiation.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is nearly time for the next scheduled dose. In that case, the missed dose should be skipped and the regular dosing schedule resumed. Patients should never double the dose to make up for a missed administration. Consistent dosing is important for maintaining therapeutic effects, so patients should be encouraged to establish a routine. If multiple doses are missed, medical advice should be sought regarding dose re-titration.
Overdose
Nitrate overdose manifests as severe hypotension with syncope, flushing, dizziness, and persistent throbbing headache. Methemoglobinemia may occur with massive overdose. Management includes placing patient in supine position with legs elevated. Volume expansion with intravenous fluids may be necessary. If severe hypotension persists, vasopressor agents may be required. Methemoglobinemia exceeding 30% may require methylene blue administration (1-2 mg/kg intravenously over 5 minutes). Hemodialysis is not effective due to high protein binding.
Storage
Store at controlled room temperature (20-25°C or 68-77°F) in the original container with lid tightly closed. Protect from moisture and light. Keep away from excessive heat and humidity. Do not store in bathroom medicine cabinet. Keep out of reach of children and pets. Do not use if tablets show signs of discoloration or deterioration. Properly discard any unused medication after expiration date.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before starting or changing any medication regimen. Individual patient response may vary, and therapeutic decisions should be based on clinical assessment. The prescribing physician should be familiar with complete prescribing information and current clinical guidelines for angina management.
Reviews
Clinical studies demonstrate that 78% of patients experience significant reduction in angina frequency with Ranol SR therapy. In a 12-week multicenter trial, 85% of patients showed improved exercise tolerance compared to baseline. Cardiologists report high satisfaction with the consistent therapeutic effect and reduced tolerance development. Patients appreciate the convenience of twice-daily dosing and reliable symptom control. Long-term follow-up studies indicate maintained efficacy over 12 months of continuous therapy with appropriate dose management.